Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Become EABM
Become Reviewer

Editorial [Hot Topic:Recent Advances in Molecular Targeting of Head and Neck Cancer (Guest Editor: Dong Moon Shin, M.D.)] promotion: free to download

Volume:7   Issue: 7
Pp: 605-605
Dong Moon Shin
DOI: 10.2174/156800907782418275

Pathobiology of Head and Neck Squamous Tumorigenesis

Volume:7   Issue: 7
Pp: 606-612
Adel K. El-Naggar
DOI: 10.2174/156800907782418338

Current Status and Future Perspectives of Chemoprevention in Head and Neck Cancer

Volume:7   Issue: 7
Pp: 623-632
Carmen M. Klass and Dong M. Shin
DOI: 10.2174/156800907782418347

Targeting Angiogenesis in Head and Neck Cancer

Volume:7   Issue: 7
Pp: 643-649
Nabil F. Saba, Dong M. Shin and Fadlo R. Khuri
DOI: 10.2174/156800907782418356

EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer

Volume:7   Issue: 7
Pp: 650-665
Igor Astsaturov, Roger B. Cohen and Paul Harari
DOI: 10.2174/156800907782418365

Recent Advances in Combined Modality Therapy for Locally Advanced Head and Neck Cancer

Volume:7   Issue: 7
Pp: 674-680
Lori J. Wirth and Marshall R. Posner
DOI: 10.2174/156800907782418329

Recent Approaches in Chemoprevention of Prostate Cancer

Volume:7   Issue: 7
Pp: 681-688
Charles Y.F. Young
DOI: 10.2174/156800907782418284

Targeting MDM2 and MDMX in Retinoblastoma

Volume:7   Issue: 7
Pp: 689-695
Nikia A. Laurie, Chie Schin-Shih and Michael A. Dyer
DOI: 10.2174/156800907782418266